Resveratrol

The evidence base for resveratrol's safety profile is notably limited in the provided studies. The available evidence consists primarily of preclinical research focused on therapeutic mechanisms rather than safety outcomes, with few completed clinical trials providing safety data.

Known Side Effects

Evidence is extremely thin regarding specific side effects from the provided studies. The preclinical research examining resveratrol's effects on neurological conditions (Parkinson's disease, Alzheimer's disease, epilepsy) and other therapeutic applications does not report adverse events or safety concerns. However, these studies are primarily mechanistic rather than safety-focused.

Contraindications

No specific contraindications are identified in the provided evidence. The research does not address populations or conditions where resveratrol should be avoided.

Drug Interactions

Limited evidence is available regarding drug interactions. One completed clinical trial (NCT03097211) examined interactions between BIA 6-512 and levodopa/benserazide combinations, but this study appears to focus on a different compound rather than resveratrol specifically. The provided evidence does not contain sufficient data to establish clinically significant drug interactions with resveratrol.

Special Populations

Evidence regarding safety in special populations is lacking. The completed clinical trials include studies in:

• Patients with diabetic retinopathy
• Overweight and obese individuals
• Elderly patients (NCT02123121 - "Resveratrol to Enhance Vitality and Vigor in Elders")
• Patients receiving antiretroviral therapy (NCT04386499)

However, the provided abstracts and trial information do not include specific safety outcomes or adverse event data for these populations.

Evidence Limitations

The safety evidence base is notably incomplete. While several clinical trials have been completed, the provided information lacks detailed safety and tolerability data. The preclinical studies focus primarily on therapeutic mechanisms and efficacy endpoints rather than comprehensive safety assessment.

---

This information is for educational purposes only and does not constitute medical advice. Consult healthcare providers before using resveratrol, especially if you have underlying health conditions or take other medications.